"Gadolinium DTPA" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
| Descriptor ID |
D019786
|
| MeSH Number(s) |
D02.092.782.590.401 D02.241.081.018.639.400 D02.691.400
|
| Concept/Terms |
Gadolinium DTPA- Gadolinium DTPA
- DTPA, Gadolinium
- Gadolinium Diethylenetriaminepenta-acetic Acid
- Diethylenetriaminepenta-acetic Acid, Gadolinium
- Gadolinium Diethylenetriaminepenta acetic Acid
- Gadopentetic Acid
- Gd-DTPA
- Gd DTPA
Gadopentetate Dimeglumine- Gadopentetate Dimeglumine
- Dimeglumine, Gadopentetate
- Gadolinium DTPA Dimeglumine Salt
- Gadolinium DTPA Dimeglumine
- Dimeglumine, Gadolinium DTPA
|
Below are MeSH descriptors whose meaning is more general than "Gadolinium DTPA".
Below are MeSH descriptors whose meaning is more specific than "Gadolinium DTPA".
This graph shows the total number of publications written about "Gadolinium DTPA" by people in this website by year, and whether "Gadolinium DTPA" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 3 | 3 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 3 | 0 | 3 |
| 2010 | 5 | 0 | 5 |
| 2011 | 2 | 2 | 4 |
| 2012 | 2 | 1 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gadolinium DTPA" by people in Profiles.
-
Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A?Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine. J Magn Reson Imaging. 2021 11; 54(5):1660-1675.
-
T1 reactivity as an imaging biomarker in myocardial tissue characterization discriminating normal, ischemic and infarcted myocardium. Int J Cardiovasc Imaging. 2019 Jul; 35(7):1319-1325.
-
The Critical Need for Pediatric and Juvenile Animal Research Addressing Gadolinium Retention in the Developing Body. Invest Radiol. 2019 02; 54(2):72-75.
-
Gadolinium Deposition in the Pediatric Brain. JAMA Pediatr. 2017 12 01; 171(12):1229.
-
Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent. AJNR Am J Neuroradiol. 2016 Dec; 37(12):2340-2347.
-
Age-independent myocardial infarct quantification by signal intensity percent infarct mapping in swine. J Magn Reson Imaging. 2016 Apr; 43(4):911-20.
-
Diagnostic confidence of computed tomography and magnetic resonance in focal liver pathology. Eur J Gastroenterol Hepatol. 2015 Jan; 27(1):97-101.
-
Infarct density distribution by MRI in the porcine model of acute and chronic myocardial infarction as a potential method transferable to the clinic. Int J Cardiovasc Imaging. 2014 Jun; 30(5):937-48.
-
Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. Radiology. 2013 Apr; 267(1):212-20.
-
Six years after. Acta Radiol. 2012 Oct 01; 53(8):827-9.